Radionuclide therapy for the treatment of microscopic ovarian carcinoma: An overview

Industrial and Engineering Chemistry Research

Volumn 39, Issue 9, 2000, Pages 3135-3139

  Whitlock, Jenny L ^a   Roeske, J C ^a   Dietz, M L ^b   Straus, C M ^a   Hines, J J ^a   Philip Horwitz, E ^a   Reba, R C ^a   Rotmensch, J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA PARTICLES; BIOMEDICAL ENGINEERING; BISMUTH; DIAGNOSIS; ONCOLOGY; RADIOISOTOPES;

MICROSCOPIC OVARIAN CARCINOMA; THERAPEUTIC UTILITIES;

RADIOTHERAPY;

BISMUTH; BISMUTH 212; RADIOISOTOPE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL CYCLE; DNA DAMAGE; DRUG MANUFACTURE; DRUG PURITY; MULTIMODALITY CANCER THERAPY; NONHUMAN; OVARY CARCINOMA; RABBIT; RADIOCHEMISTRY;

EID: 0034282759     PISSN: 08885885     EISSN: None     Source Type: Journal    
DOI: 10.1021/ie000425u     Document Type: Article

References (2)

1. McDonald, C. J. Cancer Statistics 1999: Challenges in Minority Populations. Cancer J. Clin. 1999, 49, 6.
2. Braun, A. C. The Biology of Cancer; Addison-Wesley: Reading, MA, 1974.